[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Kayembe-Kitenge T., Nkulu C.B.L., Musanzayi S.M., Kasole T.L., Ngombe L.K., Obadia P.M., Van Brusselen D., Mukoma D.K.W., Musambo T.M., Mulangu A.M., et al
While individual results vary, some people find that focusing on these nutrients as part of their overall nutrition strategy may support their goals during their weight loss journey.* *Individual results may vary
India's drug regulator has intensified surveillance over GLP-1 weight loss drugs following the March patent expiry of semaglutide, which triggered a flood of more than 40 generic versions into the market
As such, HDL-Cs causality in protection from CVD is difficult to define and is somewhat controversial, mainly due to epidemiological discrepancies between the dose-response of HDL-C levels to CVD outcomes
However, like any medication, ongoing monitoring is important